Dr. Mark Pasmantier (New York-Presbyterian/Weill Cornell Medicine, New York, NY) is a medical oncologist and hematologist specializing in the research and treatment of lung cancer. He previously served as a clinical investigator in the Early Lung Cancer Action Project centered at Weill Cornell—a groundbreaking project designed to test the value of annual repeat screening by CT scan for lung cancer, which resulted in a statewide screening project of thousands of smokers. Throughout his career, Dr. Pasmantier has collaborated with Drs. Richard T. Silver and Morton Coleman, his colleagues on CR&T’s Medical Advisory Board, to author numerous journal articles on Hodgkin’s disease, myeloma, lymphoma, ovarian carcinoma and other cancers. He was also named one of America’s top doctors by Castle Connolly and among the best doctors in New York by New York Magazine.